BETA INTERFERON AND GLATIRAMER ACETATE

Summary

That this House notes mounting evidence that disease-modifying drugs (beta interferons and glatiramer acetate) bring long-term benefits to people with MS; recognises the benefits these drugs bring in terms of improved health and maintaining independence; believes any cost-effectiveness assessment of these drugs must take full account of their effect on the lives of individuals and of the total costs of supporting a person disabled by MS; and calls upon the Government to make these drugs available through the National Health Service on the recommendation of a neurologist.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 19 December 2000

   Early Day Motion

   That this House notes mounting evidence that disease-modifying drugs (beta interferons and glatiramer acetate) bring long-term benefits to people with MS; recognises the benefits these drugs bring in terms of improved health and maintaining independence; believes any cost-effectiveness assessment of these drugs must take full account of their effect on the lives of individuals and of the total costs of supporting a person disabled by MS; and calls upon the Government to make these drugs available through the National Health Service on the recommendation of a neurologist.

   Source: Early Day Motion

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

• Paul Burstow · Liberal Democrat · Primary sponsor

Related records

No cross-record relationships stored yet.